Related Experiment Video
Updated: Mar 15, 2026

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
Published on: December 2, 2022
Planctomycetes as Novel Source of Bioactive Molecules
Ana P Graça1, Rita Calisto1, Olga M Lage1
1Departamento de Biologia, Faculdade de Ciências, Universidade do PortoPorto, Portugal; CIIMAR-Centro Interdisciplinar de Investigação Marinha e Ambiental-Universidade do PortoPorto, Portugal.
Marine bacteria called Planctomycetes, found on algae, show significant potential for producing new antimicrobial drugs. Researchers identified genes for bioactive compound production in most strains, with many extracts exhibiting antifungal and antibacterial properties.
Area of Science:
- Marine Microbiology
- Natural Products Chemistry
- Drug Discovery
Background:
- Marine organisms, particularly sponges and macroalgae, are vital sources of novel therapeutic compounds.
- Planctomycetes, prevalent in macroalgae biofilms, are emerging as promising producers of bioactive substances.
- These bacteria share genomic and life cycle characteristics with Actinobacteria, known for producing bioactive compounds.
Purpose of the Study:
- To evaluate the antimicrobial production potential of diverse Planctomycetes isolated from Portuguese macroalgae.
- To screen for genes involved in secondary metabolite biosynthesis, specifically nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS).
- To assess the antimicrobial activity of Planctomycetes extracts against various bacterial and fungal pathogens.
Main Methods:
- Screening of 40 Planctomycetes isolates using molecular assays for NRPS and PKS genes.
- Bioinformatic analysis to predict biosynthetic pathways of secondary metabolites.
- Antimicrobial activity testing of aqueous and organic extracts against *Escherichia coli*, *Pseudomonas aeruginosa*, *Staphylococcus aureus*, *Bacillus subtilis*, and *Candida albicans*.
Main Results:
- 95% of Planctomycetes harbored genes for secondary metabolite production (85% PKS-I, 55% NRPS).
- Antimicrobial activity was detected in 43% of extracts against *Candida albicans* and 54% against *Bacillus subtilis*.
- Bioactive extracts were identified from *Rhodopirellula lusitana*, *R. rubra*, *R. baltica*, *Roseimaritima ulvae*, and *Planctomyces brasiliensis*.
Conclusions:
- Planctomycetes from macroalgae biofilms possess significant genomic potential for producing antimicrobial compounds.
- The study validates the capacity of these bacteria to yield bioactive extracts with antifungal and antibacterial properties.
- Further research into molecule isolation and characterization could lead to the discovery of new pharmaceutical agents.
Related Concept Videos
Bacterial Phylum Planctomycetes
Fungal Group Zygomycota
Fungal Phylum Basidiomycota
Biofilms
Bacterial Phylum Actinobacteria
Environmental Applications of Microorganisms

